A citation-based method for searching scientific literature

D Gareth R Evans, Fiona Lalloo, Linda Ashcroft, Andrew Shenton, Tara Clancy, Andrew D Baildam, Anne Brain, Penelope Hopwood, Anthony Howell. Cancer Epidemiol Biomarkers Prev 2009
Times Cited: 97







List of co-cited articles
750 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
Kelly A Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, Jacek Gronwald, Henry Lynch, Pal Moller, Parviz Ghadirian, William D Foulkes, Jan Klijn, Eitan Friedman,[...]. Int J Cancer 2008
240
43

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
42


Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing.
A-B Skytte, A-M Gerdes, M K Andersen, L Sunde, K Brøndum-Nielsen, M Waldstrøm, S Kølvraa, D Crüger. Clin Genet 2010
71
49

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
824
34

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
695
30

Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers.
Mary S Beattie, Beth Crawford, Feng Lin, Eric Vittinghoff, John Ziegler. Genet Test Mol Biomarkers 2009
62
43

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
994
25

Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers.
Angela R Bradbury, Comfort N Ibe, James J Dignam, Shelly A Cummings, Marion Verp, Melody A White, Grazia Artioli, Laura Dudlicek, Olufunmilayo I Olopade. Genet Med 2008
66
37

Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Joanna B Madalinska, Judith Hollenstein, Eveline Bleiker, Marc van Beurden, Heiddis B Valdimarsdottir, Leon F Massuger, Katja N Gaarenstroom, Marian J E Mourits, René H M Verheijen, Eleonora B L van Dorst,[...]. J Clin Oncol 2005
164
24

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
24

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
861
21

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
21

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Amy Finch, Mario Beiner, Jan Lubinski, Henry T Lynch, Pal Moller, Barry Rosen, Joan Murphy, Parviz Ghadirian, Eitan Friedman, William D Foulkes,[...]. JAMA 2006
384
19

Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis.
R Manchanda, M Burnell, A Abdelraheim, M Johnson, A Sharma, E Benjamin, C Brunell, E Saridogan, S Gessler, D Oram,[...]. BJOG 2012
37
51

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
E J Meijers-Heijboer, L C Verhoog, C T Brekelmans, C Seynaeve, M M Tilanus-Linthorst, A Wagner, L Dukel, P Devilee, A M van den Ouweland, A N van Geel,[...]. Lancet 2000
223
18

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008
348
17

Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
L C Hartmann, D J Schaid, J E Woods, T P Crotty, J L Myers, P G Arnold, P M Petty, T A Sellers, J L Johnson, S K McDonnell,[...]. N Engl J Med 1999
912
16

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
16

Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Theresa Wagner, Henry T Lynch, Judy E Garber, Mary B Daly, Claudine Isaacs, Olufunmilayo I Olopade, Susan L Neuhausen, Laura van 't Veer,[...]. J Clin Oncol 2005
261
15

Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study.
Yvonne Brandberg, Kerstin Sandelin, Staffan Erikson, Göran Jurell, Annelie Liljegren, Annika Lindblom, Ann Lindén, Anna von Wachenfeldt, Marie Wickman, Brita Arver. J Clin Oncol 2008
141
15

Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.
Joanna B Madalinska, Marc van Beurden, Eveline M A Bleiker, Heiddis B Valdimarsdottir, Lottie Lubsen-Brandsma, Leon F Massuger, Marian J E Mourits, Katja N Gaarenstroom, Eleonora B L van Dorst, Hans van der Putten,[...]. J Clin Oncol 2007
53
26

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
482
14


The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
A Finch, K A Metcalfe, J K Chiang, L Elit, J McLaughlin, C Springate, R Demsky, J Murphy, B Rosen, S A Narod. Gynecol Oncol 2011
127
13

Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy.
M H Frost, D J Schaid, T A Sellers, J M Slezak, P G Arnold, J E Woods, P M Petty, J L Johnson, D L Sitta, S K McDonnell,[...]. JAMA 2000
209
12


Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
Tara M Friebel, Susan M Domchek, Susan L Neuhausen, Theresa Wagner, D Gareth Evans, Claudine Isaacs, Judy E Garber, Mary B Daly, Rosalind Eeles, Ellen Matloff,[...]. Clin Breast Cancer 2007
53
22

Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.
Marc D Schwartz, Elizabeth Kaufman, Beth N Peshkin, Claudine Isaacs, Chanita Hughes, Tiffani DeMarco, Clinton Finch, Caryn Lerman. J Clin Oncol 2003
95
12

The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
Joanna B Madalinska, Marc van Beurden, Eveline M A Bleiker, Heiddis B Valdimarsdottir, Judith Hollenstein, Leon F Massuger, Katja N Gaarenstroom, Marian J E Mourits, René H M Verheijen, Eleonora B L van Dorst,[...]. J Clin Oncol 2006
142
12

Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
Marc D Schwartz, Claudine Isaacs, Kristi D Graves, Elizabeth Poggi, Beth N Peshkin, Christy Gell, Clinton Finch, Scott Kelly, Kathryn L Taylor, Lauren Perley. Cancer 2012
90
13

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).
Litanja N Lodder, Petra G Frets, R Willem Trijsburg, E Johanna Meijers-Heijboer, Jan G M Klijn, Caroline Seynaeve, Albertus N van Geel, Madeleine M A Tilanus, Carina C M Bartels, Leon C Verhoog,[...]. Breast Cancer Res Treat 2002
127
11

Increased cardiovascular mortality after early bilateral oophorectomy.
Cathleen M Rivera, Brandon R Grossardt, Deborah J Rhodes, Robert D Brown, Véronique L Roger, L Joseph Melton, Walter A Rocca. Menopause 2009
264
11

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.
Jeffrey R Botkin, Ken R Smith, Robert T Croyle, Bonnie J Baty, Jean E Wylie, Debra Dutson, Anna Chan, Heidi A Hamann, Caryn Lerman, Jamie McDonald,[...]. Am J Med Genet A 2003
154
11


Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
M O Leach, C R M Boggis, A K Dixon, D F Easton, R A Eeles, D G R Evans, F J Gilbert, I Griebsch, R J C Hoff, P Kessar,[...]. Lancet 2005
687
11

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
11

Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
Kelly A Metcalfe, Jan Lubinski, Parviz Ghadirian, Henry Lynch, Charmaine Kim-Sing, Eitan Friedman, William D Foulkes, Susan Domchek, Peter Ainsworth, Claudine Isaacs,[...]. J Clin Oncol 2008
116
10

Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers.
D G Evans, K N Gaarenstroom, D Stirling, A Shenton, L Maehle, A Dørum, M Steel, F Lalloo, J Apold, M E Porteous,[...]. J Med Genet 2009
82
12

Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer.
Yoland Antill, John Reynolds, Mary-Anne Young, Judy Kirk, Katherine Tucker, Tarli Bogtstra, Shirley Wong, Tracy Dudding, Juliana Di Iulio, Kelly-Anne Phillips. Eur J Cancer 2006
33
30

Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy.
Mark Robson, Martee Hensley, Richard Barakat, Carol Brown, Dennis Chi, Elizabeth Poynor, Kenneth Offit. Gynecol Oncol 2003
96
10

Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
Hanne Meijers-Heijboer, Cecile T M Brekelmans, Marian Menke-Pluymers, Caroline Seynaeve, Astrid Baalbergen, Curt Burger, Ellen Crepin, Ans W M van den Ouweland, Bert van Geel, Jan G M Klijn. J Clin Oncol 2003
95
10

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
L C Hartmann, T A Sellers, D J Schaid, T S Frank, C L Soderberg, D L Sitta, M H Frost, C S Grant, J H Donohue, J E Woods,[...]. J Natl Cancer Inst 2001
475
10

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
Andrea Eisen, Jan Lubinski, Jan Klijn, Pal Moller, Henry T Lynch, Kenneth Offit, Barbara Weber, Tim Rebbeck, Susan L Neuhausen, Parviz Ghadirian,[...]. J Clin Oncol 2005
300
10

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo, S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C Southey,[...]. Br J Cancer 2008
299
9

Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women.
C M Julian-Reynier, L J Bouchard, D G Evans, F A Eisinger, W D Foulkes, B Kerr, I R Blancquaert, J P Moatti, H H Sobol. Cancer 2001
71
12

Risk-reduction surgery decisions in high-risk women seen for genetic counseling.
Jessica A Ray, Lois J Loescher, Molly Brewer. J Genet Couns 2005
31
29


Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study.
K Tiller, B Meiser, P Butow, M Clifton, B Thewes, M Friedlander, K Tucker. Gynecol Oncol 2002
50
18

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Anne Uyei, Susan K Peterson, Julie Erlichman, Kristine Broglio, Sandra Yekell, Kathkeen Schmeler, Karen Lu, Funda Meric-Bernstam, Chris Amos, Louise Strong,[...]. Cancer 2006
47
19


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.